Dr Kim Kennedy received the Best of Posters Award at the AGITG Annual Scientific Meeting for her poster ‘long term survival and toxicity in patients with progressive advanced neuroendocrine tumours treated with Lutetium-177-Octreotate Peptide Receptor Radionuclide Therapy: A Western Australian long term follow-up study’.